Trials / Completed
CompletedNCT03961165
BUSCLAB - Buscopan to Prevent Slow Progress in Labor
BUSCLAB - A Double Blind Randomized Placebo-Controlled Trial Investigating the Effect of Intravenous Butylscopolamine Bromide to Prevent Slow Progress in Labor
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 250 (actual)
- Sponsor
- Oslo University Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To study the effect of Butylscopolamine Bromide on duration of the active phase of first stage of labor in first time mothers who cross the alert-line for labor dystocia, according to the WHO partograph.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Butylscopolamine Bromide 20 MG/ML | 1 mL Butylscopolamine Bromide 20 mg/mL i.v. Single dose. |
| DRUG | Sodium Chloride 9mg/mL | 1 mL Sodium Chloride 9 mg/mL i.v. Single dose. |
Timeline
- Start date
- 2019-05-25
- Primary completion
- 2021-08-29
- Completion
- 2022-06-16
- First posted
- 2019-05-23
- Last updated
- 2022-12-20
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT03961165. Inclusion in this directory is not an endorsement.